“…Medicinal chemists have been continuous embarking on the synthesis of novel compounds of this chemotype due to the broad spectrum of medicinal uses associated with the benzothiazole scaffold [3]. The modified analogues of benzothiazole revealed a significant number of pharmacological properties such as antifungal [4], cyclooxygenase inhibitors [5], antimicrobial [6], anticonvulsant [7], mosquitocidal [8], anticancer [9], antioxidant [10], anti-inflammatory [11], bacterial type II topoisomerase inhibitors [12], photosensitizers [13], selective PI3Kβ inhibitors [14], topoisomerase I inhibitors [15], cytotoxic agents [16], falcipain inhibitors [17], tubulin polymerization inhibitors [18], p53 inhibitors [19], neuroprotective [20], antiacetylcholinesterase [21], vasorelaxants [22], inhibitors of the insulin releasing process [22], antiproliferative agents [23], anti-influenza [24], hemostatic agents [25], antitubercular agents [26], chemokine receptor 2 (CXCR2) inhibitors [27], EGFR inhibitors [28], cyclin-dependent kinase 2 inhibitors [29], β-amyloid imaging agents [30], α-glucosidase inhibitor [31], antidepressant [32], monoamine oxidase A/B inhibitors [33], non-carboxylic PTP1B inhibitors [34], histone deacetylase inhibitors [35], β-glucuronidase activity [36], antiviral [37], tyrosine kinase inhibitors [38], antibacterial…”